Chronic Inflammation

Acts as substrate for enzymatic generation of lipoxins and resolvins that orchestrate the active resolution of systemic inflammaging.

Acts as substrate for enzymatic generation of lipoxins and resolvins that orchestrate the active resolution of systemic inflammaging.

Provides substrate for Specialized Pro-resolving Mediators (SPMs: resolvins, protectins, maresins) to terminate sterile vascular inflammation.

Cyclic hyperventilation paired with prolonged breath retention triggers massive endogenous epinephrine release, upregulating anti-inflammatory IL-10 by nearly 2-fold and suppressing pro-inflammatory TNF-α and IL-6.

Suppresses the Senescence-Associated Secretory Phenotype (SASP) including circulating IL-6, TNF-alpha, and MMP collagenases.

Triggers a 250% surge in plasma norepinephrine, suppressing pro-inflammatory cytokine cascades and activating uncoupling protein 1 (UCP1) in brown fat.

Reprograms immune cell differentiation from inflammatory Th17 toward immunosuppressive regulatory T-cells (Tregs), drastically lowering circulating IL-6 and TNF-α.

Inhibits NF-κB activation in circulating monocytes, blunts lipid peroxidation of LDL particles, and significantly curtails coronary low-attenuation soft plaque progression.

Dramatically suppresses circulating inflammaging cytokines (IL-6 -78%, TNF-alpha -54%, hs-CRP -47%) by neutralizing systemic reactive oxygen species and NF-κB nuclear translocation.

Significantly lowers circulating high-sensitivity C-reactive protein (hs-CRP -32.4%), alleviating subclinical neurovascular and endothelial inflammation.

Oleocanthal potently inhibits inflammatory cyclooxygenase enzymes, curbing endothelial NF-kB activation and circulating inflammatory cytokines.

Potently blunts sterile systemic inflammaging by inhibiting the NLRP3 inflammasome assembly and caspase-1 activation.

Dramatically reduces visceral white adipose tissue inflammation and circulating pro-inflammatory adipokines (leptin, TNF-alpha, IL-6).

Dramatically reduces visceral white adipose tissue inflammation and circulating pro-inflammatory adipokines (leptin, TNF-alpha, IL-6).

Directly blocks the conversion of arachidonic acid into pro-inflammatory leukotrienes, halting chronic systemic vascular and visceral inflammatory cascades.

Reduces circulating inflammatory SASP cytokines and improves physical functional mobility in older adults with fibrotic lung pathology.

Suppresses pro-inflammatory cytokines and exercise-induced muscle micro-damage (creatine kinase), enhancing muscular hypertrophy and total testosterone.

Inhibits NF-kB nuclear translocation and suppresses pro-inflammatory cytokine expression (IL-6, TNF-a).

Directly suppresses NF-κB nuclear translocation and reduces synovial expression of pro-inflammatory cytokines IL-6, IL-8, and PGE2 by up to 68%.

Modulates systemic nitric oxide synthesis by balancing eNOS and iNOS, attenuating intestinal mucosal permeability (ZO-1 upregulation) and dampening systemic cytokine secretion.

Undergoes intracellular redox cycling into dihydrolipoic acid (DHLA), regenerating endogenous glutathione (GSH), vitamin C, and CoQ10 pools while quenching NF-κB inflammatory signaling.

Inhibits IκBα degradation and NF-κB nuclear translocation, suppressing systemic pro-inflammatory cytokine secretion (TNF-α, IL-6) and dampening macrophage TLR4 activation.

Suppresses NF-kB translocation and blunts systemic pro-inflammatory cytokine surges (TNF-alpha, IL-6, IL-8) through endogenously released epinephrine.

Suppresses microglial inflammatory cytokine transcription and reactive oxygen bursts, alleviating subjective anxiety and autonomic irritability in human clinical trials.

Reverses dyslipidemic metabolic syndrome markers, lowering fasting serum triglycerides by 20.4% and boosting cardioprotective HDL cholesterol by 18.2%.

Quantifies bacteremic periodontal drivers of systemic inflamma-aging, CRP elevation, and microglial priming in neurodegenerative cascades.

Downregulates the Conserved Transcriptional Response to Adversity (CTRA), suppressing IL-6 and TNF-alpha expression.

Generates aspirin-triggered resolvins and protectins (AT-RVs) through acetylated COX-2, actively switching off chronic microvascular inflammation.

Suppresses NF-kB activation in monocytes and endothelial cells, blunting systemic inflamma-aging.

Dual inhibition of COX and LOX pathways downregulates NF-kB-dependent transcription of inflammatory chemokines.

Directly inhibits nuclear translocation of NF-kB p65/p50 heterodimers, terminating downstream chemokine transcription.

Eliminates bacteremic seeding of systemic tissues, preventing endotoxin (LPS) activation of endothelial Toll-like Receptor 4 (TLR4).

Eliminates bacteremic seeding of systemic tissues, preventing endotoxin (LPS) activation of endothelial Toll-like Receptor 4 (TLR4).